Skip to main content
. Author manuscript; available in PMC: 2011 Apr 1.
Published in final edited form as: Cancer Causes Control. 2009 Dec 27;21(4):597–608. doi: 10.1007/s10552-009-9489-6

Table 4.

Associations of of polymorphisms in genes involved in folate uptake and distribution and risk of colorectal cancer among population-based families by folic acid supplementation and dietary folate intake

Multivitamin use¥ Dietary Folate

SNP* No Yes Low (103.4–306.0 mcg) High (306.1–1068 mcg)

Adjusted OR (95% CI) Adjusted OR (95% CI) p-value Adjusted OR (95% CI) Adjusted OR (95% CI) p-value
FOLR1
rs11235464 1.13 (0.59–2.15) 1.59 (0.89–2.82) 0.28 1.52 (0.45–5.12) 1.39 (0.37–5.17) 0.78
rs12361490 0.85 (0.70–1.04) 1.09 (0.90–1.33) 0.07 1.27 (0.88–1.84) 0.88 (0.62–1.26) 0.19
rs2071010 0.84 (0.62–1.14) 1.26 (0.96–1.66) 0.05 1.03 (0.63–1.68) 1.22 (0.71–2.11) 0.77
rs3016432 0.89 (0.78–1.02) 1.14 (1.00–1.30) <0.01 1.05 (0.82–1.35) 0.96 (0.76–1.21) 0.65
rs3887687 0.88 (0.70–1.10) 1.04 (0.84–1.29) 0.39 1.15 (0.76–1.74) 0.74 (0.50–1.09) 0.15
FPGS
rs1330684 0.88 (0.77–1.01) 1.05 (0.92–1.20) 0.01 1.21 (0.94–1.57) 1.13 (0.88–1.46) 0.33
rs1544105 0.90 (0.79–1.02) 1.06 (0.93–1.21) 0.02 1.20 (0.94–1.53) 1.15 (0.91–1.46) 0.34
rs4451422 0.90 (0.78–1.02) 1.06 (0.93–1.21) 0.02 1.19 (0.93–1.53) 1.14 (0.90–1.46) 0.37
rs7033913 0.87 (0.76–1.00) 1.02 (0.89–1.16) 0.04 0.82 (0.63–1.06) 0.80 (0.62–1.04) 0.19
GGH
rs10106324 0.88 (0.74–1.04) 1.14 (0.97–1.33) 0.12 1.21 (0.91–1.60) 1.32 (0.98–1.77) 0.18
rs11545078 0.74 (0.57–0.96) 0.99 (0.77–1.29) 0.97 1.17 (0.75–1.83) 0.92 (0.58–1.44) 0.59
rs11995525 0.86 (0.73–1.01) 0.98 (0.84–1.14) 0.79 0.79 (0.59–1.06) 0.84 (0.64–1.11) 0.25
rs12548933 0.96 (0.79–1.17) 1.17 (0.96–1.41) 0.11 1.33 (0.97–1.81) 0.99 (0.70–1.40) 0.14
rs13270305 0.72 (0.59–0.86) 0.99 (0.83–1.18) 0.89 0.91 (0.63–1.32) 0.82 (0.58–1.16) 0.54
rs16930092 0.87 (0.68–1.10) 1.08 (0.84–1.39) 0.56 0.76 (0.49–1.17) 0.86 (0.56–1.33) 0.44
rs17194931 0.75 (0.57–0.98) 0.98 (0.75–1.27) 0.88 1.14 (0.73–1.78) 0.91 (0.58–1.43) 0.64
rs2736683 0.89 (0.76–1.05) 0.99 (0.85–1.16) 0.93 0.81 (0.60–1.09) 0.87 (0.66–1.15) 0.34
rs3758149 0.80 (0.68–0.94) 1.05 (0.89–1.23) 0.58 0.91 (0.68–1.22) 0.82 (0.61–1.09) 0.40
rs3780126 0.96 (0.84–1.11) 1.05 (0.92–1.21) 0.45 0.91 (0.70–1.18) 0.90 (0.70–1.14) 0.67
rs4279586 0.83 (0.71–0.97) 1.09 (0.94–1.27) 0.25 1.10 (0.85–1.44) 1.15 (0.87–1.51) 0.61
rs4617146 1.04 (0.87–1.24) 1.16 (0.97–1.38) 0.10 1.04 (0.77–1.42) 0.98 (0.72–1.32) 0.92
SLC19A1
rs1051266¥ 0.89 (0.68–1.16) 1.11 (0.86–1.43) 0.54 1.11 (0.71–1.73) 0.88 (0.57–1.36) 0.70
rs12482346 0.86 (0.74–0.99) 1.02 (0.89–1.18) 0.88 1.00 (0.79–1.27) 0.96 (0.75–1.23) 0.92
rs17004785 1.17 (0.92–1.50) 1.30 (1.02–1.65) 0.03 1.52 (1.02–2.27) 1.89 (1.25–2.86) 0.01
rs2236484 0.84 (0.73–0.97) 1.04 (0.91–1.20) 0.69 1.03 (0.81–1.31) 1.00 (0.78–1.28) 0.96
rs2297291 0.87 (0.76–1.01) 1.05 (0.91–1.21) 0.65 1.00 (0.79–1.27) 0.98 (0.77–1.25) 0.97
rs2838951 0.90 (0.78–1.04) 1.05 (0.92–1.20) 0.41 0.90 (0.71–1.14) 0.83 (0.65–1.05) 0.30
rs3972 0.87 (0.69–1.11) 1.01 (0.82–1.24) 0.92 0.86 (0.58–1.28) 1.27 (0.88–1.83) 0.17
rs7499 0.88 (0.76–1.02) 1.04 (0.91–1.20) 0.69 0.95 (0.75–1.21) 0.99 (0.77–1.25) 0.91
¥

No multivitamin use: 820 cases; 1497 controls; Yes multivitamin use: 971 cases; 1346 controls;

Low dietary folate: 309 cases; 408 controls; high dietary folate: 276 cases, 429 controls;

Adjusted for age and sex and matched for center and race;

*

log-additive model;

¥

recessive model;

p-value for interaction